130 related articles for article (PubMed ID: 36372720)
1. Prevalence and Severity of Aortic Regurgitation Due to a Percutaneous Left Ventricular Assist Device (Impella 5.0): A Retrospective Observational Study.
Hotta N; Tsukinaga A; Yoshitani K; Fukushima S; Ohnishi Y
J Cardiothorac Vasc Anesth; 2023 Jan; 37(1):23-30. PubMed ID: 36372720
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural Dynamics of Aortic Regurgitation in Patients Supported With an Impella Left Ventricular Assist Device.
Butala B; Yu R; Schorr R; Gologorsky E
J Cardiothorac Vasc Anesth; 2020 Mar; 34(3):659-662. PubMed ID: 31668745
[TBL] [Abstract][Full Text] [Related]
3. Aortic insufficiency associated with Impella that required surgical intervention upon implantation of the durable left ventricular assist device.
Oishi H; Kondo T; Fujimoto K; Mutsuga M; Morimoto R; Hirano KI; Sawamura A; Kazama S; Kimura Y; Shibata N; Kato H; Arao Y; Kuwayama T; Yamaguchi S; Hiraiwa H; Okumura T; Usui A; Murohara T
J Artif Organs; 2020 Dec; 23(4):378-382. PubMed ID: 32562105
[TBL] [Abstract][Full Text] [Related]
4. Color Doppler Artifact Masking Iatrogenic Aortic Valve Injury Related to an Impella Device.
Hong E; Naseem T
J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1584-1587. PubMed ID: 30467028
[TBL] [Abstract][Full Text] [Related]
5. Treatment With Impella Increases the Risk of De Novo Aortic Insufficiency Post Left Ventricular Assist Device Implant.
Rao SD; Johnson B; Olia SE; Wald J; Medina V; Rame JE; Mazurek JA; Goldberg LR; Atluri P; Bermudez C; Acker M; Birati EY
J Card Fail; 2020 Oct; 26(10):870-875. PubMed ID: 32681883
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Percutaneous Left Ventricular Assist Device Placement on Native Valve Competency.
Hironaka CE; Ortoleva J; Zhan Y; Chen FY; Couper GS; Kapur NK; Kawabori M
ASAIO J; 2022 Apr; 68(4):541-546. PubMed ID: 34419983
[TBL] [Abstract][Full Text] [Related]
7. Protected Percutaneous Coronary Intervention of Unprotected Left Main Using Impella Ventricular Assist Device Before Transcatheter Aortic Valve Implantation: A Single-Center Experience.
Kneizeh K; Alnaimi A; Noterdaeme T; Schröder J; Altiok E; Marx N; Almalla M
J Invasive Cardiol; 2022 Mar; 34(3):E196-E201. PubMed ID: 35058376
[TBL] [Abstract][Full Text] [Related]
8. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
Yoshijima N; Yanagisawa R; Hase H; Tanaka M; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K;
Catheter Cardiovasc Interv; 2020 Jan; 95(1):35-44. PubMed ID: 30977256
[TBL] [Abstract][Full Text] [Related]
9. Outflow graft anastomosis site design could be correlated to aortic valve regurgitation under left ventricular assist device support.
Iizuka K; Nishinaka T; Ichihara Y; Miyamoto T; Yamazaki K
J Artif Organs; 2018 Jun; 21(2):150-155. PubMed ID: 29164425
[TBL] [Abstract][Full Text] [Related]
10. Mitral and aortic valve regurgitation following surgical and transcatheter perimembranous ventricular septal defect closure in children and adolescents: midterm outcomes.
Edraki M; Nobakhti M; Naghshzan A; Amoozgar H; Amirghofran A; Ghasemzadeh B; Nirooie E; Mehdizadegan N; Mohammadi H; Keshavarz K
BMC Cardiovasc Disord; 2022 Jul; 22(1):315. PubMed ID: 35840901
[TBL] [Abstract][Full Text] [Related]
11. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter aortic valve implantation in patients with a left ventricular assist device: a word of caution.
Ali J; Catarino P; Abu-Omar Y
Eur J Cardiothorac Surg; 2020 Dec; 58(6):1309-1310. PubMed ID: 32766699
[TBL] [Abstract][Full Text] [Related]
13. Differences in Cardiac Remodeling in Left-Sided Valvular Regurgitation: Implications for Optimal Definition of Significant Aortic Regurgitation.
Vejpongsa P; Xu J; Quinones MA; Shah DJ; Zoghbi WA
JACC Cardiovasc Imaging; 2022 Oct; 15(10):1730-1741. PubMed ID: 35842362
[TBL] [Abstract][Full Text] [Related]
14. Severe aortic valve regurgitation requiring mechanical aortic valve replacement following Impella device implantation.
Vila P; de Vere F; Simon A; Walker C
Perfusion; 2021 Apr; 36(3):311-314. PubMed ID: 32664788
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
Almalla M; Kersten A; Altiok E; Marx N; Schröder JW
Catheter Cardiovasc Interv; 2020 Feb; 95(3):357-362. PubMed ID: 31268621
[TBL] [Abstract][Full Text] [Related]
16. Does postoperative blood pressure influence development of aortic regurgitation following continuous-flow left ventricular assist device implantation?†.
Patil NP; Mohite PN; Sabashnikov A; Dhar D; Weymann A; Zeriouh M; Koch A; Garcia-Saez D; Zych B; Hards R; Hedger M; De Robertis F; Moza A; Bahrami T; Amrani M; Rahman-Haley S; Popov AF; Banner N; Simon AR
Eur J Cardiothorac Surg; 2016 Mar; 49(3):788-94. PubMed ID: 26108216
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter Aortic Valve Replacement for Severe Aortic Regurgitation in Patients With a Left Ventricular Assist Device.
Dhillon AS; Jones BM; Hodson RW; Korngold EC
J Invasive Cardiol; 2022 May; 34(5):E369-E373. PubMed ID: 35343915
[TBL] [Abstract][Full Text] [Related]
18. Prosthetic valve replacement for aortic leaflet tear secondary to Impella device placement.
Nishimura K; Iida M; Shimokawa T
J Artif Organs; 2020 Dec; 23(4):383-387. PubMed ID: 32632507
[TBL] [Abstract][Full Text] [Related]
19. Concomitant aortic valve repair for aortic insufficiency and implantation of left ventricle mechanical support.
Singhal AK; Bang J; Panos AL; Feider A; Hanada S; Rankin JS
J Card Surg; 2022 Jul; 37(7):2086-2089. PubMed ID: 35470913
[TBL] [Abstract][Full Text] [Related]
20. Predictors and Long-Term Impact of De Novo Aortic Regurgitation in Continuous Flow Left Ventricular Assist Devices Using Vena Contracta.
Park JR; Brady PA; Clavell AL; Maleszewski JJ; Nkomo VT; Pislaru SV; Stulak JM; Lin G
ASAIO J; 2022 May; 68(5):691-697. PubMed ID: 34506330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
